Does ginger have an effect on nausea and vomiting in patients undergoing chemotherapy?

Authors

  • Adriele Silva Freitas Hospital das Clínicas da Universidade Federal de Goiás
  • Mônica Batista Soares Hospital das Clínicas da Universidade Federal de Goiás
  • Malaine Morais Alves Machado Hospital das Clínicas da Universidade Federal de Goiás
  • Marina Brito Campos Hospital das Clínicas da Universidade Federal de Goiás.
  • Renata Costa Fernandes Hospital das Clínicas da Universidade Federal de Goiás.

DOI:

https://doi.org/10.15448/1983-652X.2018.3.30223

Keywords:

ginger, nausea, vomiting, neoplasms, chemotherapy.

Abstract

Introduction: The ginger has a potential antiemetic effect, but there are few studies which investigate its effects on patients undergoing chemotherapy.
Objective: To evaluate the effect of ginger on the control of nausea and vomiting in patients undergoing chemotherapy.
Materials and Methods: This is a clinical, randomized, triple-blind, placebo-controlled, and crossover trial. Sixteen patients were recruited, of whom 12 completed the study. Subjects were randomly assigned to receive 1 g of a ginger dry extract or placebo four days before and after chemotherapy. The nutritional status was evaluated by the Global Subjective Evaluation Produced by the Patient. The instrument for measuring the main outcome was the Multinational Association on Suportive Care in Cancer. The effects were evaluated by the Wilcoxon test for the ordinal variables and by the McNemar test for the qualitative variables.
Results: When the ginger group was compared to the placebo group, there were no difference in the number of episodes of acute and late vomiting, the intensity of late nausea, the occurrence of acute and late nausea and the occurrence of acute and late vomiting. The groups differed in acute nausea, which were lower in the placebo group.
Conclusion: Supplementation with ginger is not effective to prevent nausea and vomiting induced by chemotherapy.

Author Biographies

Adriele Silva Freitas, Hospital das Clínicas da Universidade Federal de Goiás

Nutricionista Especialista em Hematologia e Hemoterapia pelo Hospital das Clínicas da Universidade Federal de Goiás

Mônica Batista Soares, Hospital das Clínicas da Universidade Federal de Goiás

Nutricionista Especialista em Hematologia e Hemoterapia pelo Hospital das Clínicas da Universidade Federal de Goiás

Malaine Morais Alves Machado, Hospital das Clínicas da Universidade Federal de Goiás

Mestre em Nutrição e Saúde pela Universidade Federal de Goiás. Hospital das Clínicas da Universidade Federal de Goiás.

Marina Brito Campos, Hospital das Clínicas da Universidade Federal de Goiás.

Pós graduada em Nutrição Clínica e em Nutrição e Hematologia e Hemoterapia.  Hospital das Clínicas da Universidade Federal de Goiás.

Renata Costa Fernandes, Hospital das Clínicas da Universidade Federal de Goiás.

Mestre em Nutrição e Saúde pela Universidade Federal de Goiás. Hospital das Clínicas da Universidade Federal de Goiás.

References

Soares LC, Burille A, Antonacci MH, Santana MG, Schwartz E. A quimioterapia e seus efeitos adversos: relato de clientes oncológicos. Cogitare enferm. 2009;14(4):714-9.

https://doi.org/10.5380/ce.v14i4.16388

Rodrigues FSS, Polidori MM. Enfrentamento e resiliência de pacientes em tratamento quimioterápico e seus familiares. Rev Bras Cancerol. 2012;58(4):619-27.

Barbosa MBA; Instituto Nacional de Câncer (BR). Ações de enfermagem para o controle do câncer: uma proposta de integração ensino serviço. 3ª ed. Rio de Janeiro: INCA; 2008.

Molassiotis A, Saunders MP, Valle J, Wilson G, Lorigan P, Wardley A, Levine E, Cowan R, Loncaster J, Rittenberg C. A prospective observational study of chemotherapy-related náusea and vomiting in routine practice in a UK cancer center. Support Care Cancer. 2008;16(2):201-8.

https://doi.org/10.1007/s00520-007-0343-7

Roila F, Herrstedt J, Aapro M,Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clarck-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D. Guideline update for MASCC and ESMO in the prevention of chemotherapyand radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann. Oncol. 2010;21(5):232-43.

https://doi.org/10.1093/annonc/mdq194

Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Prestud AA, Temin S, Lyman GH. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2011;29(31):4189-98.

https://doi.org/10.1200/JCO.2010.34.4614

Sheikhi MA, Ebadi A, Talaeizadeh A, Rahmani H. Alternative methods to treat nausea and vomiting from cancer chemotherapy. Chemother Res Pract. 2015;2015:1-6.

https://doi.org/10.1155/2015/818759

Thamlikitkul L, Srimuninnimit V, Akewanlop C, Ithimakin S, Techawanawanna S, Korphaisarn K, Chantharasamee J, Danchaivijitr P, Soparattanapaisarn N. Efficacy of ginger for prophylaxis ofchemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin–cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study. Support Care Cancer. 2017;25(2):459-64.

https://doi.org/10.1007/s00520-016-3423-8

Ryan JL, Heckler CE, Roscoe JA, Dakhil SR, Kirshner J, Flynn PJ, Hickok JT, Morrow GR. Ginger (Zingiberofficinale) reduces acute chemotherapy induced nausea: A URCC CCOP study of 576 patients. Support Care Cancer. 2012;20(7):1479-89.

https://doi.org/10.1007/s00520-011-1236-3

Marx W, Mccarthy AL, Ried K, Mckavanagh D, Vitetta L, Sali A, Lohning A, Isenring E. The effect of a standardized ginger extract on chemotherapy-induced nausea-related quality of life in patients undergoing moderately or highly emetogenic chemotherapy: a double blind, randomized, placebo controlled trial. Nutrients. 2017;9(8). pii: E867.

https://doi.org/10.3390/nu9080867

MASCC. Multinational Association on Suportive Care in Cancer [Internet]. 2017 [capturado 2017 Jan 31]. Disponível em:

http://www.mascc.org

Gonzalez MC, Borges LR, Silveira DH, Assunção MCF, Orlandi SP. Validação da versão em português da avaliação subjetiva global produzida pelo paciente. Rev Bras Nutr Clin. 2010;25(2):102-8.

Zick SM, Ruffin MT, Lee J, Normolle DP, Siden R, Alrawi S, Brenner DE. Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting. Support Care Cancer. 2009;17(5):563-72.

https://doi.org/10.1007/s00520-008-0528-8

Dias EV, Sartori CR. Compreendendo o efeito placebo. Rev Bras Ciênc Saúde. 2015;5(4).

Hoenemeyer TW, Kaptchuk TJ, Mehta TS, Fontaine KR. Openlabel placebo treatment for cancer-related fatigue: a randomizedcontrolled clinical trial. Sci Rep. 2018;8(1):2784.

https://doi.org/10.1038/s41598-018-20993-y

Bossi P, Cortinovis D, Rocca MC, Roila F, Seminara P, Fabi A, Canova S, Verri E, Fatigoni S, Iannace A, Macci F, Ripamonti C. Searching for evidence to support the use of ginger in the prevention of chemotherapy-induced nausea and vomiting. J Altern Complement Med. 2016;22(6):486-8.

https://doi.org/10.1089/acm.2015.0315

Konmun J, Danwilai K, Ngamphaiboon N, Sripanidkulchai B, Sookprasert A, Subongkot S. A phase II randomized doubleblind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy. Med Oncol. 2017;34(4):69.

https://doi.org/10.1007/s12032-017-0931-4

Vieira NA, Tomiotto FN, Melo GP, Manchope MF, Lima NR, Oliveira GG, Watanabe MAE. Efeito anti-inflamatório do gengibre e possível via de sinalização. Semina Ciênc Biol Saúde. 2014;35(1):149-62.

https://doi.org/10.5433/1679-0367.2014v35n1p149

Gomes NS, Maio R. Avaliação subjetiva global produzida pelo próprio paciente e indicadores de risco nutricional no paciente oncológico em quimioterapia. Rev Bras Cancerol. 2015;61(3): 235-42.

Published

2018-10-17

Issue

Section

Original Articles